TRICHOGENIC EFFECT OF LOW LEVEL LASER THERAPY COMBINED WITH PLATELET-RICH PLASMA FOR THE MANAGEMENT OF ANDROGENETIC ALOPECIA

Maha Rafea Abo Eitta1, Ahmed Sadek2, Noha Abdelaziz Amer3, Nevien Samy1, Noha Abdallah1
1Dermatology unit, Medical application of laser (MAL) department, National Institute of Laser and Enhanced Sciences, Cairo University, Giza, Egypt 2Cairo Hospital for Dermatology & Venereology (Al-Haud Al-Marsoud), Cairo, Egypt 3Dermatology specialist, Minya El-Qamh General Hospital, Sharkia, Egypt Corresponding author: Ahmed Sadek, Ph.D., M.Sc., Email: askdrsadek@gmail.com

Abstract

Background: Androgenetic alopecia is a very common hair disorder in men, Topical Minoxidil and more recently low-level light therapy and Platelet-rich plasma therapy have been used in the management of Androgenetic alopecia Objectives: To assess the Trichogenic effect of low-level light therapy combined with Platelet-rich plasma in the management of Androgenetic alopecia. Patients and methods: Forty seven patients with Androgenetic alopecia were subjected to Platelet-rich plasma therapy plus low-level light therapy, affected area of all patients were treated for three months and then follow up for another three months. Efficacy was evaluated using global photography, folliscopic pictures analysis, answers for standardized hair growth questions and score of patient Gratification. Results: There was statistically significant improvement in diameter, vellus hair, terminal hair and density after treatment for three months although these improvements were decreased at three month after stoppage of treatment but still better than the baseline. Conclusion combination of low-level light therapy with Platelet-rich plasma could be a good treatment modality of Androgenetic alopecia.

Keywords:

:Androgenetic alopecia, Low-level laser therapy, Platelet-rich plasma.


Full Text:

PDF


References


(1) Galadari H, Shivakumar S, Lotti T, et al. Low-level laser therapy and narrative review of other treatment modalities in Androgenetic alopecia. Lasers Med Sci. 2020. https://doi.org/10.1007/s10103-020-02994-4. (2) Goren A, Sharma A, Dhurat R, et al. Low-dose daily aspirin reduces topical Minoxidil efficacy in Androgenetic alopecia patients. Dermatol Ther. 2018; 31(6):e12741. doi: 10.1111/dth.12741. (3) Yi Y, Qiu J, Jia J, et al. Severity of Androgenetic alopecia associated with poor sleeping habits and carnivorous eating and junk food consumption—a web-based investigation of male pattern hair loss in China. Dermatol Ther. 2020; 14:e13273. doi: 10.1111/dth.13273. (4) Fields JR, Vonu PM, Monir RL, Schoch JJ. Topical ketoconazole for the treatment of Androgenetic alopecia: a systematic review. Dermatol Ther. 2020; 33(1):e13202. doi: 10.1111/dth.13202. (5) Olsen EA. Female pattern hair loss. J Am Acad Dermatol. 2001; 45:S70-80. doi: 10.1067/mjd.2001.117426. (6) Ramos PM, Santos LDN, Mesinkovska NA, Goren A, Miot HA. Can we halt male Androgenetic alopecia progression without ant androgenic drugs? Dermatol Ther. 2020; 33(1):e13197. PMID: 31846191 DOI: 10.1111/dth.13197. (7) Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI, TrakatelliM, Finner A, Kiesewetter F, Trüeb R, Rzany B. Evidence‐based (S3) guideline for the treatment of Androgenetic alopecia in women and in men. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2011 Oct; 9:S1- 57.PMID: 21980982 DOI: 10.1111/j.1610-0379.2011.07802.x (8) Kim WS, Calderhead RG. Is light-emitting diode phototherapy (LED-LLLT) really effective? Laser Ther.2011; 20:205–15. doi: 10.5978/islsm.20.205 (9) Avci P, Gupta GK, Clark J, et al. Low-Level Laser (Light) Therapy (LLLT) for Treatment of Hair Loss. Lasers Surg Med. 2013; 9999:1. PMID: 23970445 PMCID: PMC3944668 DOI: 10.1002/lsm.22170 (10) Suchonwanit P, Chalermroj N, Khunkhet S. Low-level laser therapy for the treatment of Androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device controlled trial. Lasers Med Sci 2019 Aug; 34(6):1107-1114 doi: 10.1007/s10103-018-02699-9. Epub 2018 Dec 19. (11) Lanzafame RJ, Blanche RR, Chiacchierini RP, et al. The growth of human scalp hair in females using visible red-light laser and LED sources. Lasers Surg Med. 2014; 46:601–7. doi: 10.1002/lsm.22277 (12) Gentile P, Calabrese C, De Angelis B, et al. Impact of the Different Preparation Methods to Obtain Autologous Non-Activated Platelet-Rich Plasma (A-PRP) and Activated Platelet-Rich Plasma (AA-PRP) in Plastic Surgery: Wound Healing and Hair Regrowth Evaluation. Int J Mol Sci. 2020; 9:21(2). doi: 10.3390/ijms21020431 (13) Stevens J, Khetarpal S. Platelet-rich plasma for Androgenetic alopecia: a review of the literature and proposed treatment protocol. Int J Women’s Dermatol 2019; 5(1):46–51. doi:10.1016/j.ijwd.2018.08.004. (14) Gupta M, Mysore V. Classifications of patterned hair loss: a review. Journal of cutaneous and aesthetic surgery. 2016 Jan; 9(1):3. PMID: 27081243 PMCID: PMC4812885 DOI: 10.4103/0974-2077.178536 (15) Verma K, Tegta GR, Verma G, Gupta M, Negi A, Sharma R. A study to compare the efficacy of platelet rich plasma and Minoxidil therapy for the treatment of Androgenetic alopecia. Int j Trichology. 2019 Mar; 11(2):68. PMID: 31007475PMCID: PMC6463452 DOI: 10.4103/ijt.ijt_64_18 (16) Otberg N, Finner AM, Shapiro J. Androgenetic alopecia. Endocrinol Metab Clin North Am. 2007; 36(2):379–398. PMID: 17543725 DOI: 10.1016/j.ecl.2007.03.004 (17) Ghanaat M. Types of hair loss and treatment options, including the novel low-level light therapy and its proposed mechanism. South Med J. 2010; 103(9):917–921. PMID: 20689478 DOI: 10.1097/SMJ.0b013e3181ebcf71 (18) Itami S, Inui S. Role of androgen in mesenchymal epithelial interactions in human hair follicle. J Investig Dermatol Symp Proc. 2005; 10(3):209–211. PMID: 16382666 DOI: 10.1111/j.1087-0024.2005.10107.x (19) Hoffmann R, Happle R. Current understanding of Androgenetic alopecia. Part I: Etiopathogenesis. Eur J Dermatol. 2000; 10(4):319–327. PMID: 10846263 (20) Rogers NE, Avram MR. Medical treatments for male and female pattern hair loss. J Am Acad Dermatol. 2008; 59(4):547–566. Quiz 567–548. PMID: 18793935.DOI: 10.1016/j.jaad.2008.07.001 (21) Darwin E, Heyes A, Hirt PA, Wikramanayake TC, Jimenez JJ. Low-level laser therapy for the treatment of androgenic alopecia: a review. Lasers Med Sci. 2018 Feb; 33(2):425-434. doi: 10.1007/s10103-017-2385-5. Epub 2017 Dec 21. PMID: 29270707. (22) Marwah M, Godse K, Patil S, Nadkarni N: Is there sufficient research data to use platelet rich plasma in dermatology? Int J Trichology 2014; 6: 35–36.PMID: 25114455 PMCID: PMC4124695 DOI: 10.4103/0974- 7753.136763 (23) Dhillon RS, Schwarz EM, Maloney MD: Platelet-rich plasma therapy – future or trend? Arthritis Res Ther 2012; 14: 21PMID: 22894643PMCID: PMC3580559 DOI: 10.1186/ar3914 (24) Gentile P, Dionisi L, Pizzicannella J, de Angelis B, de Fazio D, Garcovich S. A randomized blinded retrospective study: the combined use of micro-needling technique, low-level laser therapy and autologous non- activated platelet-rich plasma improves hair re-growth in patients with androgenic alopecia. Expert Opin Biol Ther. 2020 Sep; 20(9):1099-1109. doi: 10.1080/14712598.2020.1797676. Epub 2020 Jul 27. PMID: 32678725. (25) Lubart R, Eichler M, Lavi R, Friedman H, Shainberg A. Low energy laser irradiation promotes cellular redox activity. Photomed Laser Surg. 2005; 23(1):3–9. PMID: 15782024 DOI: 10.1089/pho.2005.23.3 (26) Eells JT, Wong-Riley MT, Ver Hoeve J, Henry M, Buchman EV, Kane MP, et al. Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Mitochondrion.2004; 4(5– 6):559–67.PMID: 16120414 DOI: 10.1016/j.mito.2004.07.033 (27) Pastore D, Greco M, Passarella S. Specific helium-neon laser sensitivity of the purified cytochrome c oxidase. Int J Radiat Biol.2000; 76(6):863–70.PMID: 10902741DOI: 10.1080/09553000050029020 (28) Arany PR, Nayak RS, Hallikerimath S, Limaye AM, Kale AD, Kondaiah P. Activation of latent TGF- beta1 by low-power laser in vitro correlates with increased TGF-beta1 levels in laser enhanced oral wound healing. Wound Repair Regen. 2007; 15(6):866–74. PMID: 18028135 DOI: 10.1111/j.1524-475X.2007.00306.x (29) de Lima FM, Villaverde AB, Albertini R, Correa JC, Carvalho RL, Munin E, et al. Dual effect of low-level laser therapy (LLLT) on the acute lung inflammation induced by intestinal ischemia and reperfusion: action on anti- and pro-inflammatory cytokines. Lasers Surg Med. 2011; 43(5):410–20. PMID: 21674546 DOI: 10.1002/lsm.21053 (30) Jaworsky C, Kligman AM, Murphy GF. Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis. Br J Dermatol. 1992; 127(3):239–46. PMID: 1390168 DOI: 10.1111/j.1365-2133.1992.tb00121.x (31) Mafra de Lima F, Villaverde AB, Salgado MA, Castro-Faria-Neto HC, Munin E, Albertini R, et al. Low intensity laser therapy (LLL-T) in vivo acts on the Neutrophils recruitment and Chemokines/ cytokines levels in a model of acute pulmonary inflammation induced by aerosol of lipopolysaccharide from Escherichia coli in rat. J Photochem Photobiol B. 2010; 101(3): 271–8. PMID: 20728373 DOI: 10.1016/j.jphotobiol.2010.07.012 (32) Magro CM, Rossi A, Poe J, Manhas-Bhutani S, Sadick N. The role of inflammation and immunity in the pathogenesis of Androgenetic alopecia. J Drugs Dermatol. 2011; 10(12):1404–11. PMID: 22134564 (33) Sakurai Y, Yamaguchi M, Abiko Y. Inhibitory effect of low-level laser irradiation on LPS-stimulated prostaglandin E2 production and cyclooxygenase-2 in human gingival fibroblasts. Eur J Oral Sci. 2000; 108(1):29– 34. PMID: 10706474 DOI: 10.1034/j.1600-0722.2000.00783.x (34) Akiyama M, Smith LT, Holbrook KA: Growth factor and growth factor receptor localization in the hair follicle bulge and associated tissue in human fetus. J Invest Dermatol 1996; 106: 391–396. PMID: 8648166 DOI: 10.1111/1523-1747.ep12343381 (35) Gkini M-A, Kouskoukis A-E, Tripsianis G, Rigopoulos D, Kouskoukis K: Study of platelet-rich plasma injections in the treatment of Androgenetic alopecia through a one-year period. J Cutan Aesthet Surg 2014; 7: 213– 219. PMID: 25722600 PMCID: PMC4338465, doi: 10.4103/0974-2077.150743 (36) Cervelli V, Garcovich S, Bielli A, Cervelli G, Curcio BC, Scioli MG, Orlandi A, Gentile P:The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histo Morphometric evaluation. Biomed Res Int 2014; 2014: 760709. (37) Gentile P, Cole JP, Cole MA, et al. Evaluation of Not-Activated and Activated PRP in Hair Loss Treatment: Role of Growth Factor and Cytokine Concentrations Obtained by Different Collection Systems. Int. J. Mol. Sci. 2017;18: 408. PMID: 28216604 PMCID: PMC5343942, doi: 10.3390/ijms18020408

Refbacks

  • There are currently no refbacks.